DUXAP10 and hepatocellular carcinoma: Several studies have reported that DUXAP10 is aberrantly expressed in numerous human cancers, such as HCC, BC, NSCLC, glioma, RCC, PTC, PCa, CML, OC, PC, GC, CRC, ESCC, and OSCC.